To investigate whether breast cancer cells express ICAM-1, which would be used for targeting drug combinations in GT DcNPs, we evaluated a LFA1-P peptide mimic of ICAM-1 ligand: LFA-1 peptide immobilized on GT DcNPs. Here, ICAM1 is linked to breast cancer.